WEDNESDAY, April 24, 2024 (HealthDay News) — A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says. That’s because the U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the risk of heartContinue Reading

WEDNESDAY, April 3, 2024 (HealthDay News) — Research into germs that travel through the human digestive tract shows that some may promote obesity while others might help prevent it. Not only that, but those microbes may act differently in men versus women, the same study found. “Our findings reveal howContinue Reading